APA

Shoukry H. S., Ammar H. I., Rashed L. A., Zikri M. B., Shamaa A. A., Abou Elfadl S. G., Rub E. A., Saravanan S. & Dhingra S. (20170926). Prophylactic supplementation of resveratrol is more effective than its therapeutic use against doxorubicin induced cardiotoxicity. : PloS one.

Chicago

Shoukry Heba Samy, Ammar Hania Ibrahim, Rashed Laila Ahmed, Zikri Maha Balegh, Shamaa Ashraf Ali, Abou Elfadl Sahar Gamal, Rub Ejlal Abu-Al, Saravanan Sekaran and Dhingra Sanjiv. 20170926. Prophylactic supplementation of resveratrol is more effective than its therapeutic use against doxorubicin induced cardiotoxicity. : PloS one.

Harvard

Shoukry H. S., Ammar H. I., Rashed L. A., Zikri M. B., Shamaa A. A., Abou Elfadl S. G., Rub E. A., Saravanan S. and Dhingra S. (20170926). Prophylactic supplementation of resveratrol is more effective than its therapeutic use against doxorubicin induced cardiotoxicity. : PloS one.

MLA

Shoukry Heba Samy, Ammar Hania Ibrahim, Rashed Laila Ahmed, Zikri Maha Balegh, Shamaa Ashraf Ali, Abou Elfadl Sahar Gamal, Rub Ejlal Abu-Al, Saravanan Sekaran and Dhingra Sanjiv. Prophylactic supplementation of resveratrol is more effective than its therapeutic use against doxorubicin induced cardiotoxicity. : PloS one. 20170926.